Studies genetic markers that may predict outcomes in kidney cancer
Looks at genetic biomarkers in people with kidney cancer, using samples and new recruits.
Plain-language title generated from the registry record
Registry title: Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
Key facts
- Where
- Roskilde, DenmarkSee the site
Where in Denmark
- Zealand University HospitalRoskilde, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Zealand University Hospital
- Trial code
- NCT03414827
- Record updated
- 30 January 2024
- Original description
Recruitment of participants to the study takes place at the urological department at Zealand University Hospital, Roskilde, Feb. 2018-April 2018. 10 people with diagnosis of renal cancer should be recruited in phases 1. Subsequently, biological materials from 100 patients with kidney cancer will be used from the national Biobank. In phase 3, 10 patients will be recruited for the final gene test.Read full original descriptionShow less
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
Recruitment of participants to the study takes place at the urological department at Zealand University Hospital, Roskilde, Feb. 2018-April 2018. 10 people with diagnosis of renal cancer should be recruited in phases 1. Subsequently, biological materials from 100 patients with kidney cancer will be used from the national Biobank. In phase 3, 10 patients will be recruited for the final gene test.
Inclusion: Patients who have been diagnosed with kidney cancer.
Exclusion: Patients without signs of malignancy at final histology report; Incapacitated patients.